フルコナゾール
Fluconazole
Fluconazole (UK-49858)
別名: Diflucan · UK-49858 · Fluconazolum
VetSheet 獣医チームが監修更新日 2026年4月5日エビデンスに基づく獣医学リファレンス
用量は獣医専門家向けの臨床参考資料です。必ず最新の医薬品情報および個別症例に基づいて確認してください。
動物種別用量
🌎 NA — North America🌍 EU — Europe
犬
| 適応 | 用量 | 経路 | 頻度 | 期間 | 地域 |
|---|---|---|---|---|---|
| Cryptococcosis, candidiasis, systemic mycoses, nasal aspergillosis | 2.5-5 mg/kg PO or IV q12-24h | PO/IV | q12-24h | 56-84 days | 🌎 NA |
| Fungal meningitis | 5-8 mg/kg PO or IV q12h OR 8-12 mg/kg PO or IV once daily (q24h) | PO/IV | q12h or q24h | 56-84 days | 🌎 NA |
| Urinary candidiasis | 5-10 mg/kg PO q24h | PO | q24h | 21-42 days | 🌎 NA |
| Urinary Candida glabrata infection | 12 mg/kg PO once daily | PO | q24h | 21-42 days | 🌎 NA |
| Cryptococcosis | 5 mg/kg PO once or twice daily | PO | q12h or q24h | At least 2 months beyond resolution of clinical signs | 🌎 NA |
| Blastomycosis | 5 mg/kg PO q12h | PO | q12h | 60 days | 🌎 NA |
| Cryptococcosis | 5-15 mg/kg PO q12-24h | PO | q12-24h | 6-10 months | 🌎 NA |
| Treatment of Malassezia (may be safer than itraconazole or ketoconazole in dogs with hepatic disease) | 5 mg/kg PO once daily | PO | q24h | — | 🌎 NA |
| Systemic treatment of Malassezia dermatitis | 5 mg/kg PO once daily | PO | q24h | — | 🌎 NA |
| Recurrent Malassezia dermatitis | 5 mg/kg PO 3 times per week | PO | 3 times per week | — | 🌎 NA |
| Systemic treatment of Malassezia dermatitis | 2-5 mg/kg PO once daily (q24h) | PO | q24h | — | 🌎 NA |
| Nasal aspergillosis (alternative to itraconazole or terbinafine) | 2.5-5 mg/kg PO q12h | PO | q12h | 3-6 months | 🌎 NA |
- Cryptococcosis, candidiasis, systemic mycoses, nasal aspergillosis: Often treat neurologic ocular cryptococcosis for at least 12 weeks or 2 weeks after CSF exam shows resolution
- Nasal aspergillosis (alternative to itraconazole or terbinafine): Cure rates up to 60%
猫
| 適応 | 用量 | 経路 | 頻度 | 期間 | 地域 |
|---|---|---|---|---|---|
| Nasal or dermal cryptococcosis | 5-10 mg/kg PO q12-24h, or 10 mg/kg PO q24h | PO | q12-24h | — | 🌎 NA |
| CNS, intraocular, or multisystemic cryptococcosis | 50-100 mg/cat PO or IV q12h | PO/IV | q12h | — | 🌎 NA |
| CNS, intraocular or multisystemic mycoses | 50 mg/cat PO once daily (q24h) | PO | q24h | — | 🌎 NA |
| Cryptococcosis | 50 mg (total dose) PO twice daily | PO | q12h | 1 month beyond resolution of clinical signs | 🌎 NA |
| Cryptococcosis | 50 mg (total dose) PO twice daily | PO | q12h | At least 2 months beyond resolution of clinical signs | 🌎 NA |
- Nasal or dermal cryptococcosis: For most infections, 50 mg/cat PO once daily achieves adequate therapeutic levels
- CNS, intraocular, or multisystemic cryptococcosis: Often treat neurologic ocular cryptococcosis for at least 12 weeks or 2 weeks after CSF exam shows resolution
小型哺乳類
| 適応 | 用量 | 経路 | 頻度 | 期間 | 地域 |
|---|---|---|---|---|---|
| General (Rabbits) | 25-43 mg/kg slow IV q12h | IV | q12h | — | 🌎 NA |
鳥
| 適応 | 用量 | 経路 | 頻度 | 期間 | 地域 |
|---|---|---|---|---|---|
| Candidiasis (cockatoos, parrots) | 20 mg/kg PO q24-48h or 10 mg/kg PO q24h | PO | q24-48h | — | 🌎 NA |
| Candidiasis (cockatiels) | 10 mg/kg fluconazole PO suspension and 100 mg/mL fluconazole treated drinking water | PO | — | — | 🌎 NA |
| Alternate treatment of aspergillosis | 5-10 mg/kg PO once daily | PO | q24h | up to 6 weeks | 🌎 NA |
- Candidiasis (cockatoos, parrots): Likely effective for C. albicans. C. galabrata and C. papasilosis may have higher MICs.
- Candidiasis (cockatiels): Maintained plasma levels above the MIC for most strains of Candida albicans
- Alternate treatment of aspergillosis: With or after amphotericin B
馬
| 適応 | 用量 | 経路 | 頻度 | 期間 | 地域 |
|---|---|---|---|---|---|
| C. immitis infection or Candida bacteremia | Loading dose of 14 mg/kg followed by 5 mg/kg PO once daily | PO | q24h | — | 🌎 NA |
| Fungal keratitis | 1 mg/kg PO q24h | PO | q24h | — | 🌎 NA |
- Fungal keratitis: Anecdotal reports of successful treatment
用量は獣医専門家向けの臨床参考資料です。必ず最新の医薬品情報および個別症例に基づいて確認してください。
概要
フルコナゾールは全身性のトリアゾール系抗真菌薬です。ケトコナゾールなどの古い第一世代アゾール系とは異なり、親水性が高く、中枢神経系(CSF)、眼、尿路への移行性に優れています。
臨床のポイント: 吸収に胃酸を必要としないため、制酸薬を服用している患者でも経口バイオアベイラビリティが非常に安定しています。さらに、ケトコナゾールに比べて哺乳類のシトクロムP450酵素への親和性がはるかに低いため、哺乳類のステロイドホルモン合成への影響が最小限であり、一般的に副作用が少ないです。
作用機序
Fluconazole acts by inhibiting the fungal cytochrome P450-dependent enzyme lanosterol 14-α-demethylase.
Lanosterol → (blocked by fluconazole) → Ergosterol
This depletion of ergosterol disrupts the synthesis of the fungal cell membrane, increasing its permeability and causing leakage of essential cellular contents. It also impairs the uptake of purine and pyrimidine precursors. Fluconazole is primarily fungistatic.
安全性・警告
禁忌
- Hypersensitivity to fluconazole or other azole antifungals
- Budgerigars (reportedly toxic)
- Pregnant animals
- Lactating animals
有害事象
- Inappetence
- Vomiting
- Diarrhea
- Hepatotoxicity (rare)
- Headache (humans)
- Increased liver enzymes (humans)
- Exfoliative skin disorders (humans)
- Thrombocytopenia (humans)
- Nausea
- Diarrhoea
注意事項
Use with caution in patients with hepatic impairment. Because fluconazole is eliminated primarily by the kidneys, doses or dosing intervals may need to be adjusted in patients with renal impairment. Safety during pregnancy has not been established (FDA Category C); use with caution in nursing dams as it is excreted in milk. Reportedly toxic to budgerigars.
医薬品相互作用
May be antagonistic against Aspergillus or Candida; clinical importance unclear
Plasma concentrations of buspirone may be elevated
May increase cisapride levels and the possibility for toxicity
May inhibit the metabolism of corticosteroids; potential for increased adverse effects
May inhibit the metabolism of cyclophosphamide and its metabolites; potential for increased toxicity
Increases cyclosporine levels; dosage of cyclosporine may need to be decreased by 29%-51%
Increased fluconazole concentrations
May increase fentanyl levels
Increased midazolam levels and effects
May increase NSAID plasma levels; increased risk for adverse effects
Increased risk for cardiotoxicity
May decrease fluconazole efficacy; fluconazole may increase rifampin levels
Increased theophylline concentrations
May exacerbate the effects of tricyclic antidepressants (e.g., clomipramine, amitriptyline)
May increase levels of agents like glipizide or glyburide; hypoglycemia possible
May inhibit vinca alkaloid metabolism
May cause increased prothrombin times
Fluconazole inhibits cytochrome P450-dependent liver enzymes, which may increase plasma theophylline concentrations.
Co-administration has led to terfenadine toxicity in humans.
Fluconazole increases ciclosporin blood levels.
監視
- Clinical efficacy
- Liver function tests (occasional, with long-term therapy)
- Liver enzyme panel (ALT, AST, ALP, Bilirubin) prior to and during prolonged therapy
- Renal function (BUN, Creatinine)
- Resolution of clinical signs of fungal infection
- Therapeutic drug monitoring for concurrent medications like ciclosporin or theophylline
薬物動態
吸収
Rapidly and nearly completely absorbed (90%) after oral administration. Gastric pH or the presence of food do not appreciably alter oral bioavailability.
分布
Low protein binding and widely distributed throughout the body. Penetrates well into the CSF, eye, and peritoneal fluid.
代謝
Minimal hepatic metabolism compared to other azole antifungals.
消失
Eliminated primarily via the kidneys and achieves high concentrations in the urine.
過剰投与
There is limited information on acute toxicity in domestic animals. In rodents, massive overdoses (1-2 g/kg) caused respiratory depression, salivation, lacrimation, urinary incontinence, and cyanosis, leading to death within several days.
Treatment: If a massive overdose occurs, consider gut emptying (emesis or gastric lavage) if recent, and provide supportive therapy as required. Fluconazole may be removed by hemodialysis or peritoneal dialysis.
製品
製剤
- Tablets
- Powder for oral suspension
- Injection
- 150 mg oral capsule
- 200 mg oral capsule
- 40 mg/ml oral suspension
- 2 mg/ml injectable solution
ヒト用医薬品
- Fluconazole Oral Tablets: 50 mg, 100 mg, 150 mg, & 200 mg
- Fluconazole Powder for Oral Suspension: 10 mg/mL & 40 mg/mL (when reconstituted)
- Fluconazole Injection: 2 mg/mL in 100 mL or 200 mL bottles or Viaflex Plus
- Diflucan 50 mg, 150 mg, 200 mg capsules
- Diflucan 40 mg/ml oral suspension
- Diflucan 2 mg/ml injectable solution
規制ステータス
POM (Prescription Only Medicine)
POM-V (Prescription Only Medicine - Veterinarian)
規制データなし: 🇺🇸 US · 🇭🇰 HK · 🇹🇼 TW · 🇯🇵 JP · 🇰🇷 KR · 🇦🇺 AU
保管・安定性
Tablets should be stored at temperatures less than 30°C in tight containers. Injection should be stored at 5-30°C (5-25°C for Viaflex bags); avoid freezing. Do not add additives to the injection.
飼主向け情報
- 根気が必要です: 真菌感染症の治療には長い時間がかかります。治療は通常数週間から数ヶ月続きます。ペットの症状が良くなったように見えても、感染が再発する可能性があるため、早めに薬をやめないでください。
- 投与方法: フルコナゾールは食事と一緒でも、空腹時でも非常によく吸収されます。
- 副作用に注意: 一般的に非常に安全ですが、食欲不振、嘔吐、下痢に注意してください。これらの症状が見られた場合は獣医師に連絡してください。
- 費用: 治療が長期にわたるため費用がかさむことがありますが、ジェネリック医薬品の普及により手頃になってきています。
VetSheet医薬品リファレンスは獣医専門家の臨床意思決定支援を目的としており、専門的判断または製造業者の最新医薬品情報の代替にはなりません。
